Clinical Trial Update: Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer [Phase 2]

View source ↗

Summary

Phase II trial of pembrolizumab with carboplatin and paclitaxel in ovarian cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pembrolizumab (pembrolizumab)
• Taxol (paclitaxel)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-22